GOP bill would use opioid funds to jump-start clinical trials on psychedelic-based trauma treatment

A Republican state Rep. Jaime Green proposes using opioid settlement funds to conduct clinical trials on ibogaine, a Schedule 1 psychedelic drug, to treat addiction and trauma disorders. The bill, House Bill 6020, aims to allocate $50 million for research through a consortium involving states, manufacturers, and universities.